Premium Tedizolid API in Pakistan: Reliable Raw Material Supply for Pharmaceutical Formulators

Product Name: Tedizolid / Tedizolid Phosphate (Active Pharmaceutical Ingredient)

Supplier / Distributor: Morgan

Therapeutic Category: Oxazolidinone Antibiotic

Indications: Acute Bacterial Skin and Skin Structure Infections (ABSSSI)

Compliance Notice: This technical data page is strictly for B2B pharmaceutical manufacturers, contract manufacturing organizations (CMOs), and analytical laboratories. The Tedizolid distributed by Morgan is a highly purified Active Pharmaceutical Ingredient (API) intended exclusively for commercial formulation and laboratory R&D. It is not a finished drug product.

About Morgan: Morgan Chemicals (Pvt.) Ltd. is a pharmaceutical raw material trading and distribution company. We source APIs from DRAP-registered and internationally certified manufacturers and supply exclusively to licensed pharmaceutical companies, CMOs, and research facilities. We do not manufacture APIs or sell finished medicines.

Product Overview and Mechanism of Action

Tedizolid is a highly potent, next-generation small-molecule Active Pharmaceutical Ingredient (API). In antimicrobial pharmacology, it is classified as an oxazolidinone antibiotic. For pharmaceutical manufacturers focused on expanding their anti-infective portfolios, this API represents a critical advancement in combating multidrug-resistant Gram-positive pathogens, including methicillin-resistant Staphylococcus aureus (MRSA), vancomycin-resistant Enterococcus (VRE), and Streptococcus pyogenes.

To overcome the poor aqueous solubility of the active moiety, this API is frequently supplied and formulated as Tedizolid Phosphate, a water-soluble ester prodrug. Upon administration, the prodrug is rapidly and extensively converted by endogenous phosphatases into the biologically active moiety, Tedizolid.

At the cellular level, the active API functions by inhibiting bacterial protein synthesis. It binds selectively to the 50S subunit of the bacterial ribosome, specifically at the peptidyl transferase center.

By occupying this highly conserved ribosomal site, Tedizolid prevents the formation of the 70S initiation complex, effectively halting the translation process and stopping the growth of susceptible bacteria. Unlike legacy oxazolidinones, structural modifications in the Tedizolid molecule (specifically the addition of a tetrazole ring and substitution of the fluorine atom) confer increased target site affinity and potency, even against strains that have developed resistance to earlier linezolid-based treatments.

For pharmaceutical formulation scientists, integrating this API enables the development of highly effective, short-course antimicrobial therapeutics suitable for both oral and intravenous administration.

Sourcing Tedizolid in Pakistan: Morgan’s Supply Network

Developing and commercializing advanced anti-infective formulations requires a highly resilient and traceable raw material pipeline. Procuring specialty antibiotic APIs for local commercial manufacturing frequently involves navigating extended lead times, stringent customs bottlenecks, and highly complex regulatory compliance. Sourcing TEDIZOLID Pakistan through Morgan’s localized distribution network mitigates these complex supply chain risks.

Morgan sources commercial-scale and pilot-scale quantities from global manufacturing partners operating in strict adherence to ICH Q7 Good Manufacturing Practice (GMP) guidelines. Partnering with Morgan as your primary supply vendor secures several operational provisions for your manufacturing facility:

• DRAP Submission Assistance: Morgan coordinates with DRAP-registered API manufacturers to obtain and forward the necessary compliance documentation on your behalf. This includes the open part of the Drug Master File (DMF), comprehensive impurity profiles, and accelerated stability data to strictly support your Drug Regulatory Authority of Pakistan (DRAP) dossier submissions.
• Supply Chain Stability: Our localized API inventory management eliminates international transit variables. Whether you require a standard batch or are scaling up a high-volume TEDIZOLID api Pakistan procurement order, we help ensure that your commercial batch schedules and production timelines are met without costly line stoppages or raw material shortages.
• Batch-to-Batch Uniformity: Every shipment coordinated by Morgan includes a detailed Certificate of Analysis (CoA) issued by the original manufacturer. We ensure our supplied batches maintain consistent chemical purity, controlled moisture limits, and a precise particle size distribution (PSD) for predictable behavior during compounding, lyophilization, or tablet compression processes.

Technical Specifications for QA & R&D

The Tedizolid (and Tedizolid Phosphate) API supplied by Morgan undergoes exacting analytical testing at the source to meet current international pharmacopeial standards.

• Chemical Name (Prodrug): [(5R)-(3-{3-fluoro-4-[6-(2-methyl-2H-tetrazol-5-yl)pyridin-3-yl]phenyl}-2-oxo-1,3-oxazolidin-5-yl)methyl] dihydrogen phosphate
• CAS Number: 856866-72-3 (Tedizolid) / 856867-55-5 (Tedizolid Phosphate)
• Appearance: White to off-white or light yellow crystalline solid powder
• Molecular Formula: C17H16FN6O6P (Phosphate Form)
• Molecular Weight: 450.32 g/mol (Phosphate Form)
• Assay / Purity (HPLC): ≥ 99.0%
• Solubility Profile: The phosphate prodrug exhibits favorable aqueous solubility. Detailed solubility parameters across standard solvents and aqueous buffers are documented in the technical data sheet to assist your analytical R&D teams with IV formulation and tablet dissolution profiling.

Manufacturing and Handling Guidelines for Formulators

As a highly potent antimicrobial agent, facilities processing this API must enforce strict occupational exposure limits (OEL) and environmental controls to protect personnel and prevent the inadvertent generation of antimicrobial resistance in the facility environment.

• Storage Conditions: Store the raw API powder in securely closed, light-resistant containers. Maintain climate-controlled conditions as specified by the batch protocol (typically controlled room temperature, strictly protected from excessive heat and ambient humidity) to prevent degradation and hydrolysis of the phosphate ester.
• Occupational Safety: Personnel handling the pure API powder must follow advanced industrial containment protocols. Processing requires appropriate Personal Protective Equipment (PPE), including P3/N95 industrial dust masks or respirators, chemical-resistant nitrile gloves, and full protective facility garments. Dispensing, milling, and compounding stages must be executed within localized exhaust ventilation systems or dedicated negative-pressure weighing booths to prevent the inhalation of airborne particulates and facility cross-contamination.

Distributor Disclaimer: Morgan Chemicals is a pharmaceutical raw material trading and distribution company. This API is sourced from DRAP-registered, GMP-certified manufacturing partners. Morgan Chemicals does not manufacture APIs, does not hold DRAP manufacturing registration, and does not sell finished medicines. This product is supplied exclusively to licensed pharmaceutical companies, CMOs, and research facilities in Pakistan — not for individual or consumer sale.